🇺🇸 FDA
Patent

US 11766032

Genetically modified non-human animals expressing human EPO

granted A61KA61K49/0008

Quick answer

US patent 11766032 (Genetically modified non-human animals expressing human EPO) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K49/0008